Ceftriaxone Treatment Protocol
The standard treatment protocol for ceftriaxone (Orblicef) in adults is 1-2 grams administered intravenously once daily, with a maximum daily dose not exceeding 4 grams. 1, 2
Dosing Guidelines by Patient Population
Adult Dosing
- Standard dosing: 1-2 grams IV once daily 1, 2
- Severe infections: 2 grams IV every 12 hours (4 grams total daily) 1
- Bacterial meningitis: 100 mg/kg/day (not exceeding 4 grams daily) 1
- Uncomplicated gonorrhea: 250 mg IM as a single dose 2
- Surgical prophylaxis: 1 gram IV administered 30 minutes to 2 hours before surgery 2
Pediatric Dosing
- Children <45 kg with uncomplicated infections: 50-75 mg/kg/day given once daily or in divided doses twice daily (maximum 2 grams daily) 1, 2
- Children <45 kg with meningitis: Initial dose of 100 mg/kg, followed by 100 mg/kg/day (maximum 4 grams daily) 2
- Children <45 kg with uncomplicated gonorrhea: 125 mg IM single dose 3, 1
- Children <45 kg with bacteremia/arthritis: 50 mg/kg/day (maximum 1 gram) for 7 days 3, 1
Neonatal Dosing
- Neonates ≤7 days old: 50 mg/kg/day given every 24 hours 1
- Neonates >7 days old and ≤2000g: 50 mg/kg/day given every 24 hours 1
- Neonates >7 days old and >2000g: 50-75 mg/kg/day given every 24 hours 1
Administration Guidelines
Intravenous Administration
- Adult IV infusion should be administered over 30 minutes 1
- Neonatal IV infusion should be administered over 60 minutes to reduce the risk of bilirubin encephalopathy 1, 2
- Do not use diluents containing calcium (e.g., Ringer's solution or Hartmann's solution) 2
- Do not administer simultaneously with calcium-containing IV solutions 2
Intramuscular Administration
- Reconstitute with appropriate diluent 2
- Inject well within the body of a relatively large muscle 2
- Aspiration helps to avoid unintentional injection into a blood vessel 2
Duration of Therapy
- General infections: Continue therapy for at least 2 days after signs and symptoms of infection have disappeared 2
- Usual duration: 4-14 days; longer therapy may be required for complicated infections 2
- Streptococcal infections: Continue for at least 10 days 2
Special Considerations
Renal and Hepatic Impairment
- No dosage adjustment necessary for patients with impairment of renal or hepatic function up to 2 grams per day, provided there is no severe impairment 2
Elderly Patients
- No modification required for elderly patients up to 2 grams per day, provided there is no severe renal and hepatic impairment 2
Contraindications
- Hyperbilirubinemic neonates, especially premature infants 2
- Neonates (≤28 days) requiring calcium-containing IV solutions 2
Outpatient Therapy Considerations
Ceftriaxone's long half-life (5.8-8.7 hours) 4 makes it suitable for outpatient parenteral antibiotic therapy (OPAT) in appropriate cases:
- Patient should be afebrile and clinically improving 3
- Patient should have received at least 5 days of inpatient therapy and monitoring 3
- Reliable intravenous access must be established 3
- Patient must have access to medical advice/care from the OPAT team 24 hours a day 3
- For outpatient therapy, ceftriaxone 2g twice daily IV can be used, or 4g once daily IV after the first 24 hours of therapy 3
Clinical Monitoring
- Assess clinical response within 48-72 hours of initiating therapy 1
- No routine therapeutic drug monitoring is required 1
- For patients with suspected treatment failure, reevaluate diagnosis and consider alternative antimicrobial therapy
Ceftriaxone's once-daily dosing schedule offers significant advantages in terms of convenience and cost savings compared to antibiotics requiring multiple daily doses 5, particularly in outpatient settings 6.